Anticancer Mammalian Target of Rapamycin (mTOR) Signaling Pathway Inhibitors: Current Status, Challenges and Future Prospects in Management of Epilepsy

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 15, Iss. 8, 2016-09 ,pp. : 945-955

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of the mammalian target of rapamycin

By Dancey Janet E  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 3, 2005-03 ,pp. : 313-328

Informa Healthcare

Access to resources Recommend Favorite

Next generation of mammalian target of rapamycin inhibitors for the treatment of cancer

By Nelson Valerie   Altman Jessica K   Platanias Leonidas C  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 6, 2013-09 ,pp. : 715-722

Informa Healthcare

Access to resources Recommend Favorite

Mammalian Target of Rapamycin (mTOR) Inhibitors as Anti-Cancer Agents

By  

Current Cancer Drug Targets, Vol. 4, Iss. 8, 2004-12 ,pp. : 621-635

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Signaling Network in Cancer Stem Cells

By  

Current Medicinal Chemistry, Vol. 18, Iss. 18, 2011-06 ,pp. : 2715-2726

Bentham Science Publishers

Access to resources Recommend Favorite